PTGXProtagonist Therapeutics, Inc.

$151.50

What is the market doing?

What the tape says about PTGX

Protagonist Therapeutics, Inc. is +197% over the past year while the S&P 500 is +23%: 175 points ahead of the market.

+197%

1-year return · S&P 500 +23%

vs 200-day average
+51%

vs 200-day average · a clear uptrend

RSI (14)
58

RSI (14) · neutral

Below its 52-week high
−4.5%

Below its 52-week high

2024-08-06$26.78 – $158.64 · dashed line: 200-day average2026-08-26
Details
Last close2026-08-26
$151.50
1 monthS&P 500 +3.7%
+12%
1 yearS&P 500 +23%
+197%
5 yearsS&P 500 +87%
+209%
vs 50-day average$129.59
+17%
52-week high
$158.63
52-week low
$51.07
Annualised volatility
57%
Insider buying, net, 6 monthsForms 3/4/5 to 2026-06-30
−$36M
Calendar-year price return
YearReturn
2026 (year to date)+73%
2025+126%
2024+68%
2023+110%
2022−68%
2021+70%
2020+186%
2019+4.8%
2018−68%
2017−5.4%
Average return by calendar month, 2016–2026
MonthYearsPositiveAverage
Jan106 of 10+3.1%
Feb105 of 10+0.49%
Mar105 of 10+7.8%
Apr102 of 10−12%
May107 of 10+19%
Jun108 of 10+11%
Jul106 of 10+1.4%
Aug108 of 10+16%
Sep105 of 10+0.52%
Oct104 of 10+4.0%
Nov106 of 10+7.7%
Dec105 of 10+1.4%

End-of-day closes from IEX; the S&P 500 comparison uses SPY over the same window. Prices are a reference point, not a basis for trading decisions.